The ”Germany hepatitis C testing market” is set to gain traction from the rising initiatives taken by the government of this country to eliminate the occurrences of the disease. In August 2020, BMJ Open, for instance, published that Germany is likely to showcase a surge of 70% in the hepatitis C diagnosis rates by 2030. This information is given by Fortune Business Insights™ in a new study, titled, “Germany Hepatitis C Testing Market, 2020-2027.” The study further mentions that the market size is projected to grow from USD 80.1 million in 2020 to USD 121.4 million in 2027 at a CAGR of 6.1% in the 2020-2027 period. It stood at USD 106.8 million in 2019.
Increasing Usage of Resources in COVID-19 Testing to Affect Growth Severely
The COVID-19 pandemic is anticipated to severely impact the market for Germany hepatitis C testing because of stringent nationwide lockdown implemented by the government of this country. Also, the increasing usage of resources required for hepatitis C testing was extensively utilized for managing the transmission of coronavirus. We are offering unique research reports to help you come out of this grave situation by adopting numerous strategies.
Major Germany Hepatitis C Testing Market Key players covered in the report include:
- Abbott (Abbott Park, U.S.)
- Roche Diagnostics (Roche Diagnostics GmbH) (F. Hoffmann-La Roche Ltd ) (Basel, Switzerland)
- Siemens Healthcare GmbH (Erlangen, Germany)
- Bio-Rad Laboratories, Inc. (Hercules, U.S.)
- DiaSorin S.p.A. (Saluggia, Italy)
- Other Prominent Players
Get Request a Sample Copy of the Germany Hepatitis C Testing Report:
Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.
Germany Hepatitis C Testing Market Analysis 2021:
The market for Germany hepatitis C testing comprises regulatory raw material suppliers, firms, and processors present in the supply network. Our analysts have used both primary and secondary research methods to obtain quantitative and qualitative data about the demand and supply sides. They have also analyzed competitive developments, such as agreements, new product launches, partnerships, joint ventures, and mergers & acquisitions. Lastly, the report includes profiles of the renowned players and the strategies adopted by them to compete with rivals.
Screening of General Population for HVC Antibodies to Boost HCV Serologic Tests Segment
By application, the market is segregated into PCR and ELISA. Based on the end-user, it is fragmented into diagnostics labs, hospitals, and others. Based on test types, it is trifurcated into HCV genotype tests, HCV RNA tests, and HCV serologic tests (HCV Ab). Amongst these, the HCV serologic tests (HCV Ab) segment is expected to dominate in the forthcoming years by procuring the largest Germany hepatitis C testing market share. The urgent need to screen vulnerable and general population for HCV antibodies is likely to propel the segment, thereby driving the demand for hepatitis C testing in Germany. On the other hand, the HCV RNA tests segment generated 6.1% in terms of share in 2019.
Key Players Focus on Expanding Their Presence by Following WHO’s Norms
The market is semi-consolidated with the presence of a handful of emerging and established companies. Most of them are aiming to broaden their presence in the country. To do so, they are striving to meet the WHO’s guidelines for eliminating hepatitis C. Below is one of the latest industry developments:
- January 2021: The World Health Organization (WHO) published new information about the membership of the Guidelines Development Group (GDG) to develop guidance of hepatitis C self-testing.
Have Any Query? Ask Our Experts:
Table of Content:
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of hepatitis C in Germany
- Regulatory and Reimbursement Scenario
- Key Industry Developments
- Number of Hepatitis C Tests in Germany
- Technological Advancements in Testing
- Impact of COVID-19 Outbreak on the Germany Hepatitis C Testing Market
- Germany Hepatitis C Testing Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Test Type
- HCV Serologic Tests (HCV Ab)
- HCV RNA Tests
- HCV Genotype Tests
- Market Analysis, Insights and Forecast – By Technology Type
- Market Analysis, Insights and Forecast – By End-user
- Diagnostics Labs
- Competitive Analysis
- Key Industry Developments
- Germany Market Share Analysis (2020)
- Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- F. Hoffmann-La Roche Ltd
- Siemens Healthcare GmbH
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- Other Prominent Players
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Related Reports :